Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Cinnamon vs Pioglitazone (Actos): Cinnamon has the stronger overall evidence (6.8 vs 4/10); they're alternatives for manage blood sugar — the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
Cinnamon wins 3 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
1 of 1 studies with measurable effects showed benefit.
Top outcomes
Verdict
Mostly mechanism / observational
Top outcomes
Shared outcomes (2)
Outcomes where both Cinnamon and Pioglitazone (Actos) have evidence — compare verdict strength side-by-side.
1000-6000mg (1-6g) cinnamon powder daily, or 250-500mg standardized extract; prefer Ceylon for regular use
with-meals
Ceylon cinnamon powder or standardized aqueous extract
Off-label metabolic use mirrors diabetes dosing (e.g. 15–45 mg once daily) under a clinician. A prescription drug; not an approved longevity regimen.
morning
Oral tablet (pioglitazone)
4-12 weeks
4-12 weeks
8-12 weeks
8-12 weeks
Weeks to months
Months to years
Months
Throughout use
The effect of cinnamon supplementation on glycemic control in patients with type 2 diabetes mellitus: An updated systematic review and dose-response meta-analysis of randomized controlled trials
Phytotherapy research : PTR (2024) · Meta analysis
Significant reduction in fasting blood sugar (SMD −1.32; 95% CI −1.77 to −0.87; p<0.001)
Effects of cinnamon supplementation on metabolic biomarkers in individuals with type 2 diabetes
Nutrition reviews (2025) · Meta analysis
Improvements in glycemic and lipid biomarkers reported
Efficacy and safety of cinnamon in type 2 diabetes mellitus and pre-diabetes patients: A meta-analysis and meta-regression
Diabetes research and clinical practice (2019) · Meta analysis
Significant reduction in fasting blood glucose
Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
The New England journal of medicine (2016) · Rct · n=3876
IRIS randomized trial in patients with insulin resistance but no diabetes after recent stroke/TIA (n=3,876)
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.
Lancet (London, England) (2005) · Rct · n=5238
PROactive randomized trial in high-cardiovascular-risk type 2 diabetics (n=5,238)
Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus: A Randomized Trial.
Annals of internal medicine (2016) · Rct
Randomized, placebo-controlled trial of long-term pioglitazone in NASH with prediabetes/type 2 diabetes
Cinnamon has a higher evidence score (6.8/10 vs 4/10) and wins in 3 of 3 categories.
For manage blood sugar, Cinnamon has a higher relevance score (88 vs 62).
No known interactions between Cinnamon and Pioglitazone (Actos) have been documented in our database. However, always consult a healthcare provider before combining supplements.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.